BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Souza AC, Tsuji T, Baranova IN, Bocharov AV, Wilkins KJ, Street JM, Alvarez-Prats A, Hu X, Eggerman T, Yuen PS, Star RA. TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression. Physiol Rep 2015;3:e12558. [PMID: 26416975 DOI: 10.14814/phy2.12558] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Oliveira KC, Zambom FFF, Albino AH, Alarcon Arias SC, Ávila VF, Faustino VD, Malheiros DMAC, Camara NOS, Fujihara CK, Zatz R. NF-κB blockade during short-term l-NAME and salt overload strongly attenuates the late development of chronic kidney disease. Am J Physiol Renal Physiol 2020;319:F215-28. [PMID: 32463727 DOI: 10.1152/ajprenal.00495.2019] [Reference Citation Analysis]
2 Xu Z, Li W, Han J, Zou C, Huang W, Yu W, Shan X, Lum H, Li X, Liang G. Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2). Sci Rep 2017;7:44911. [PMID: 28322341 DOI: 10.1038/srep44911] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 8.6] [Reference Citation Analysis]
3 Dusabimana T, Kim SR, Park EJ, Je J, Jeong K, Yun SP, Kim HJ, Kim H, Park SW. P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response. Mol Metab 2020;42:101089. [PMID: 32987187 DOI: 10.1016/j.molmet.2020.101089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Sharma TP, Curry S, McDowell CM. Effects of Toll-Like Receptor 4 Inhibition on Transforming Growth Factor-β2 Signaling in the Human Trabecular Meshwork. J Ocul Pharmacol Ther 2020;36:170-8. [PMID: 31834824 DOI: 10.1089/jop.2019.0076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Castellano G, Stasi A, Franzin R, Sallustio F, Divella C, Spinelli A, Netti GS, Fiaccadori E, Cantaluppi V, Crovace A, Staffieri F, Lacitignola L, Grandaliano G, Simone S, Pertosa GB, Gesualdo L. LPS-Binding Protein Modulates Acute Renal Fibrosis by Inducing Pericyte-to-Myofibroblast Trans-Differentiation through TLR-4 Signaling. Int J Mol Sci 2019;20:E3682. [PMID: 31357597 DOI: 10.3390/ijms20153682] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
6 Yacov N, Feldman B, Volkov A, Ishai E, Breitbart E, Mendel I. Treatment with lecinoxoids attenuates focal and segmental glomerulosclerosis development in nephrectomized rats. Basic Clin Pharmacol Toxicol 2019;124:131-43. [PMID: 30125459 DOI: 10.1111/bcpt.13114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yamada Y, Harada M, Hashimoto K, Guo R, Nakajima T, Kashihara T, Yamada M, Aoyama T, Kamijo Y. Impact of chronic kidney dysfunction on serum Sulfatides and its metabolic pathway in mice. Glycoconj J 2019;36:1-11. [PMID: 30536036 DOI: 10.1007/s10719-018-9850-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Poli G, Fabi C, Bellet MM, Costantini C, Nunziangeli L, Romani L, Brancorsini S. Epigenetic Mechanisms of Inflammasome Regulation. Int J Mol Sci 2020;21:E5758. [PMID: 32796686 DOI: 10.3390/ijms21165758] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
9 Zhang Y, Su X, Zou F, Xu T, Pan P, Hu C. Toll-like receptor-4 deficiency alleviates chronic intermittent hypoxia-induced renal injury, inflammation, and fibrosis. Sleep Breath 2019;23:503-13. [PMID: 30099700 DOI: 10.1007/s11325-018-1704-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
10 Hung TV, Wanatanbe J, Yonejima Y, Hisa K, Yamamoto Y, Suzuki T. Exopolysaccharides from Leuconostoc mesenteroides attenuate chronic kidney disease in mice by protecting the intestinal barrier. Journal of Functional Foods 2019;52:276-83. [DOI: 10.1016/j.jff.2018.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
11 Bai C, Zhu Y, Dong Q, Zhang Y. Chronic intermittent hypoxia induces the pyroptosis of renal tubular epithelial cells by activating the NLRP3 inflammasome. Bioengineered 2022;13:7528-40. [PMID: 35263214 DOI: 10.1080/21655979.2022.2047394] [Reference Citation Analysis]
12 Li X, Zou Y, Fu YY, Xing J, Wang KY, Wan PZ, Wang M, Zhai XY. Ibudilast Attenuates Folic Acid-Induced Acute Kidney Injury by Blocking Pyroptosis Through TLR4-Mediated NF-κB and MAPK Signaling Pathways. Front Pharmacol 2021;12:650283. [PMID: 34025417 DOI: 10.3389/fphar.2021.650283] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Eltoweissy M, Dihazi GH, Müller GA, Asif AR, Dihazi H. Protein DJ-1 and its anti-oxidative stress function play an important role in renal cell mediated response to profibrotic agents. Mol BioSyst 2016;12:1842-59. [DOI: 10.1039/c5mb00887e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
14 Jin LW, Pan M, Ye HY, Zheng Y, Chen Y, Huang WW, Xu XY, Zheng SB. Down-regulation of the long non-coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR-217-TLR4 pathway. Exp Physiol 2019;104:220-30. [PMID: 30414341 DOI: 10.1113/EP087190] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
15 Hou L, Lin Z, Xu A, Le G, Ge L, Liu S, Muhmood A, Gan F, Huang K. Combined protective effects of icariin and selenomethionine on novel chronic tubulointerstitial nephropathy models in vivo and in vitro. Br J Nutr 2021;:1-11. [PMID: 33663624 DOI: 10.1017/S0007114521000787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Wakashin H, Heymann J, Roshanravan H, Daneshpajouhnejad P, Rosenberg A, Shin MK, Hoek M, Kopp JB. APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stress. BMC Nephrol 2020;21:371. [PMID: 32854642 DOI: 10.1186/s12882-020-01995-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Dagher PC, Hato T, Mang HE, Plotkin Z, Richardson QV, Massad M, Mai E, Kuehl SE, Graham P, Kumar R, Sutton TA. Inhibition of Toll-Like Receptor 4 Signaling Mitigates Microvascular Loss but Not Fibrosis in a Model of Ischemic Acute Kidney Injury. Int J Mol Sci 2016;17:E647. [PMID: 27136544 DOI: 10.3390/ijms17050647] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
18 Xu Z, Zou C, Yu W, Xu S, Huang L, Khan Z, Wang J, Liang G, Wang Y. Inhibition of STAT3 activation mediated by toll-like receptor 4 attenuates angiotensin II-induced renal fibrosis and dysfunction. Br J Pharmacol 2019;176:2627-41. [PMID: 30958891 DOI: 10.1111/bph.14686] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
19 Vázquez-Carballo C, Guerrero-Hue M, García-Caballero C, Rayego-Mateos S, Opazo-Ríos L, Morgado-Pascual JL, Herencia-Bellido C, Vallejo-Mudarra M, Cortegano I, Gaspar ML, de Andrés B, Egido J, Moreno JA. Toll-Like Receptors in Acute Kidney Injury. Int J Mol Sci 2021;22:E816. [PMID: 33467524 DOI: 10.3390/ijms22020816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Zhang Y, Liu Y, Bi X, Hu C, Ding F, Ding W. Therapeutic Approaches in Mitochondrial Dysfunction, Inflammation, and Autophagy in Uremic Cachexia: Role of Aerobic Exercise. Mediators Inflamm 2019;2019:2789014. [PMID: 31530994 DOI: 10.1155/2019/2789014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Van Beusecum JP, Zhang S, Beltran E, Cook AK, Tobin RP, Newell-Rogers MK, Inscho EW. Antagonism of major histocompatibility complex class II invariant chain peptide during chronic lipopolysaccharide treatment rescues autoregulatory behavior. Am J Physiol Renal Physiol 2019;317:F957-66. [PMID: 31432707 DOI: 10.1152/ajprenal.00164.2019] [Reference Citation Analysis]
22 Li J, Tan YJ, Wang MZ, Sun Y, Li GY, Wang QL, Yao JC, Yue J, Liu Z, Zhang GM, Ren YS. Loganetin protects against rhabdomyolysis-induced acute kidney injury by modulating the toll-like receptor 4 signalling pathway. Br J Pharmacol 2019;176:1106-21. [PMID: 30706443 DOI: 10.1111/bph.14595] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
23 Lee H, Fessler MB, Qu P, Heymann J, Kopp JB. Macrophage polarization in innate immune responses contributing to pathogenesis of chronic kidney disease. BMC Nephrol 2020;21:270. [PMID: 32660446 DOI: 10.1186/s12882-020-01921-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
24 Hukriede NA, Soranno DE, Sander V, Perreau T, Starr MC, Yuen PST, Siskind LJ, Hutchens MP, Davidson AJ, Burmeister DM, Faubel S, de Caestecker MP. Experimental models of acute kidney injury for translational research. Nat Rev Nephrol 2022. [PMID: 35173348 DOI: 10.1038/s41581-022-00539-2] [Reference Citation Analysis]
25 Kurata A, Tachibana Y, Takahashi T, Horiba N. Novel AXL-specific inhibitor ameliorates kidney dysfunction through the inhibition of epithelial-to-mesenchymal transition of renal tubular cells. PLoS One 2020;15:e0232055. [PMID: 32324796 DOI: 10.1371/journal.pone.0232055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Nunes KP, de Oliveira AA, Mowry FE, Biancardi VC. Targeting toll-like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension? Br J Pharmacol 2019;176:1864-79. [PMID: 29981161 DOI: 10.1111/bph.14438] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
27 De Miguel C, Obi IE, Ho DH, Loria AS, Pollock JS. Early life stress induces immune priming in kidneys of adult male rats. Am J Physiol Renal Physiol 2018;314:F343-55. [PMID: 28971994 DOI: 10.1152/ajprenal.00590.2016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
28 Yan C, Li B, Fan F, Du Y, Ma R, Cheng XD, Li XY, Zhang B, Yu Q, Wang YG, Tang RX, Zheng KY. The roles of Toll-like receptor 4 in the pathogenesis of pathogen-associated biliary fibrosis caused by Clonorchis sinensis. Sci Rep 2017;7:3909. [PMID: 28634394 DOI: 10.1038/s41598-017-04018-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
29 Braun F, Rinschen M, Buchner D, Bohl K, Plagmann I, Bachurski D, Richard Späth M, Antczak P, Göbel H, Klein C, Lackmann JW, Kretz O, Puelles VG, Wahba R, Hallek M, Schermer B, Benzing T, Huber TB, Beyer A, Stippel D, Kurschat CE, Müller RU. The proteomic landscape of small urinary extracellular vesicles during kidney transplantation. J Extracell Vesicles 2020;10:e12026. [PMID: 33304478 DOI: 10.1002/jev2.12026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Tang S, Jiang X, Wu L, Chen S, Chen L, Jiang J, Yan P, Wang F, Tu K, Wang D, Gu J, Zhao L. Toll-like receptor 4 shRNA attenuates lipopolysaccharide-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells in rats. Biomed Pharmacother 2018;107:1210-7. [PMID: 30257335 DOI: 10.1016/j.biopha.2018.08.071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
31 Sun S, He M, Wang Y, Yang H, Al-Abed Y. Folic acid derived-P5779 mimetics regulate DAMP-mediated inflammation through disruption of HMGB1:TLR4:MD-2 axes. PLoS One 2018;13:e0193028. [PMID: 29447234 DOI: 10.1371/journal.pone.0193028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
32 Kumazoe M, Yamashita M, Nakamura Y, Takamatsu K, Bae J, Yamashita S, Yamada S, Onda H, Nojiri T, Kangawa K, Tachibana H. Green Tea Polyphenol EGCG Upregulates Tollip Expression by Suppressing Elf-1 Expression. J Immunol 2017;199:3261-9. [PMID: 28954885 DOI: 10.4049/jimmunol.1601822] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
33 Chen G, Zhang W, Kong L, Wang C, Lai X, Yu X, Guo Y, Wu J, Ma Q, Tsai F. Qiguiyin Decoction Improves Multidrug-Resistant Pseudomonas aeruginosa Infection in Rats by Regulating Inflammatory Cytokines and the TLR4/MyD88/NF-κB Signaling Pathway. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/5066434] [Reference Citation Analysis]
34 Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, Scalia R, Eguchi S. Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology. Physiol Rev 2018;98:1627-738. [PMID: 29873596 DOI: 10.1152/physrev.00038.2017] [Cited by in Crossref: 280] [Cited by in F6Publishing: 260] [Article Influence: 70.0] [Reference Citation Analysis]
35 Yu J, Mao S, Zhang Y, Gong W, Jia Z, Huang S, Zhang A. MnTBAP Therapy Attenuates Renal Fibrosis in Mice with 5/6 Nephrectomy. Oxid Med Cell Longev 2016;2016:7496930. [PMID: 26989454 DOI: 10.1155/2016/7496930] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
36 Ebener S, Barnowski S, Wotzkow C, Marti TM, Lopez-Rodriguez E, Crestani B, Blank F, Schmid RA, Geiser T, Funke M. Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF. Am J Physiol Lung Cell Mol Physiol 2017;312:L42-55. [PMID: 27815256 DOI: 10.1152/ajplung.00119.2016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
37 Van Beusecum JP, Zhang S, Cook AK, Inscho EW. Acute toll-like receptor 4 activation impairs rat renal microvascular autoregulatory behaviour. Acta Physiol (Oxf) 2017;221:204-20. [PMID: 28544543 DOI: 10.1111/apha.12899] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
38 Lee EK, Chung KW, Kim YR, Ha S, Kim SD, Kim DH, Jung KJ, Lee B, Im E, Yu BP, Chung HY. Small RNAs induce the activation of the pro-inflammatory TLR7 signaling pathway in aged rat kidney. Aging Cell 2017;16:1026-34. [PMID: 28665028 DOI: 10.1111/acel.12629] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
39 Kiser C, Gonul CP, Olcum M, Genc S. Inhibitory effects of sulforaphane on NLRP3 inflammasome activation. Mol Immunol 2021;140:175-85. [PMID: 34717147 DOI: 10.1016/j.molimm.2021.10.014] [Reference Citation Analysis]
40 Chen J, Li D, Luo E. Telbivudine antagonizes TLR4 to inhibit the epithelial-to-mesenchymal transition in human proximal tubular epithelial cells in vitro. Int Immunopharmacol 2019;74:105683. [PMID: 31220697 DOI: 10.1016/j.intimp.2019.105683] [Reference Citation Analysis]
41 Gong W, Mao S, Yu J, Song J, Jia Z, Huang S, Zhang A. NLRP3 deletion protects against renal fibrosis and attenuates mitochondrial abnormality in mouse with 5/6 nephrectomy. American Journal of Physiology-Renal Physiology 2016;310:F1081-8. [DOI: 10.1152/ajprenal.00534.2015] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 7.0] [Reference Citation Analysis]
42 Mohamed HE, Asker ME, Keshawy MM, Hasan RA, Mahmoud YK. Inhibition of tumor necrosis factor-α enhanced the antifibrotic effect of empagliflozin in an animal model with renal insulin resistance. Mol Cell Biochem 2020;466:45-54. [PMID: 31933108 DOI: 10.1007/s11010-020-03686-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
43 Song Y, Bai Z, Zhang Y, Chen J, Chen M, Zhang Y, Zhang X, Mai H, Wang B, Lin Y, Gu S. Protective effects of endothelial progenitor cell microvesicles on Ang II‑induced rat kidney cell injury. Mol Med Rep 2022;25:4. [PMID: 34738620 DOI: 10.3892/mmr.2021.12520] [Reference Citation Analysis]
44 Martos-Rus C, Katz-Greenberg G, Lin Z, Serrano E, Whitaker-Menezes D, Domingo-Vidal M, Roche M, Ramaswamy K, Hooper DC, Falkner B, Martinez Cantarin MP. Macrophage and adipocyte interaction as a source of inflammation in kidney disease. Sci Rep 2021;11:2974. [PMID: 33536542 DOI: 10.1038/s41598-021-82685-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Mir SA, Biswas N, Cheung W, Wan J, Webster N, Macedo E, O'Connor DT, Vaingankar SM. Chromogranin A pathway: from pathogenic molecule to renal disease. J Hypertens 2020;38:456-66. [PMID: 31714338 DOI: 10.1097/HJH.0000000000002295] [Reference Citation Analysis]
46 Chen Z, Gao X, Jiao Y, Qiu Y, Wang A, Yu M, Che F, Li S, Liu J, Li J, Zhang H, Yu C, Li G, Gao Y, Pan L, Sun W, Guo J, Cao B, Zhu Y, Xu H. Tanshinone IIA Exerts Anti-Inflammatory and Immune-Regulating Effects on Vulnerable Atherosclerotic Plaque Partially via the TLR4/MyD88/NF-κB Signal Pathway. Front Pharmacol 2019;10:850. [PMID: 31402870 DOI: 10.3389/fphar.2019.00850] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
47 Majumder S, Pushpakumar S, Juin SK, Jala VR, Sen U. Toll-like receptor 4 mutation protects the kidney from Ang-II-induced hypertensive injury. Pharmacol Res 2021;175:106030. [PMID: 34896544 DOI: 10.1016/j.phrs.2021.106030] [Reference Citation Analysis]
48 Liu F, Wang L, Qi H, Wang J, Wang Y, Jiang W, Xu L, Liu N, Zhuang S. Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease. Clin Sci (Lond) 2017;131:2125-43. [PMID: 28646122 DOI: 10.1042/CS20170134] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
49 Fanelli C, Arias SCA, Machado FG, Okuma JK, Malheiros DMAC, Azevedo H, Moreira-Filho CA, Camara NOS, Fujihara CK, Zatz R. Innate And Adaptive Immunity are Progressively Activated in Parallel with Renal Injury in the 5/6 Renal Ablation Model. Sci Rep 2017;7:3192. [PMID: 28600543 DOI: 10.1038/s41598-017-02915-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
50 Hou HT, Wang YN, Shao SZ, Fu S, Huang XP, Wang XH. High calcium diet alleviates 5/6 nephrectomy-induced bone deteriorations of lumbar vertebrae in mice. Exp Ther Med 2018;15:3483-8. [PMID: 29545872 DOI: 10.3892/etm.2018.5866] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Mohamad HE, Asker ME, Keshawy MM, Abdel Aal SM, Mahmoud YK. Infliximab ameliorates tumor necrosis factor-alpha exacerbated renal insulin resistance induced in rats by regulating insulin signaling pathway. Eur J Pharmacol 2020;872:172959. [PMID: 32004528 DOI: 10.1016/j.ejphar.2020.172959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Stasi A, Franzin R, Divella C, Sallustio F, Curci C, Picerno A, Pontrelli P, Staffieri F, Lacitignola L, Crovace A, Cantaluppi V, Medica D, Ronco C, de Cal M, Lorenzin A, Zanella M, Pertosa GB, Stallone G, Gesualdo L, Castellano G. PMMA-Based Continuous Hemofiltration Modulated Complement Activation and Renal Dysfunction in LPS-Induced Acute Kidney Injury. Front Immunol 2021;12:605212. [PMID: 33868226 DOI: 10.3389/fimmu.2021.605212] [Reference Citation Analysis]
53 Zhao T, Zhang H, Yin X, Zhao H, Ma L, Yan M, Peng L, Wang Q, Dong X, Li P. Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats. Biomed Pharmacother 2020;129:110325. [PMID: 32535383 DOI: 10.1016/j.biopha.2020.110325] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
54 Tsao CW, Hsu YJ, Chang TC, Wu ST, Cha TL, Liu CY. A High Phosphorus Diet Impairs Testicular Function and Spermatogenesis in Male Mice with Chronic Kidney Disease. Nutrients 2020;12:E2624. [PMID: 32872125 DOI: 10.3390/nu12092624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Esposito P, La Porta E, Grignano MA, Verzola D, Milanesi S, Ansaldo F, Gregorini M, Libetta C, Garibotto G, Rampino T. Soluble Toll-like Receptor 4: A New Player in Subclinical Inflammation and Malnutrition in Hemodialysis Patients. J Ren Nutr 2018;28:259-64. [PMID: 29429793 DOI: 10.1053/j.jrn.2017.11.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
56 Yokoo K, Yamamoto Y, Suzuki T. Ammonia impairs tight junction barriers by inducing mitochondrial dysfunction in Caco-2 cells. FASEB J 2021;35:e21854. [PMID: 34597422 DOI: 10.1096/fj.202100758R] [Reference Citation Analysis]
57 Lazaridis A, Gavriilaki E, Douma S, Gkaliagkousi E. Toll-Like Receptors in the Pathogenesis of Essential Hypertension. A Forthcoming Immune-Driven Theory in Full Effect. Int J Mol Sci 2021;22:3451. [PMID: 33810594 DOI: 10.3390/ijms22073451] [Reference Citation Analysis]